Group items tagged

A Lecture by Reinhold Vieth, Professor, Departments of Nutritional Sciences and Laboratory Medicine and Pathobiology, Mount Sinai Hospital. Presentation Date: Friday, October 21, 2005 (works in Internet Explorer, but not properly in Firefox (slides don't change in Firefox)).

Viral gastroenteritis, also known as stomach flu, is an inflammation of the mucous coating of the stomach and intestines caused by certain groups of viruses. They settled in the epithelial cells of the mucosa, where they multiply and cause damage to the normal structure and function. The stomach flu is a highly infectious and very common - every year there are tens of millions. Rotavirus. Rotaviruses are the leading cause of stomach flu in infants and young children. Incubation was continued for 1 to 3 days. Usually, the infection is accompanied by watery diarrhea, vomiting, fever and muscular pain for 3 to 7 days. Rotaviruses can infect and adults in contact with the ailing child. In adults, the stomach flu symptoms less severe. Calicivirus. Cause infections in people of all ages. Noroviruses are the most common calicivirus and the most common cause of stomach flu in adults. Often reaching epidemic. Usually epidemics broke out from October to April, but are possible at any time of year. Typical stomach flu symptoms include nausea, vomiting, abdominal pain, fatigue, headache and muscle aches. The symptoms started 1-2 days after contact with the virus and still 1 to 3 days. Adenoviruses. Mainly infects children under 2 years. There are 49 types of adenoviruses, one of which affects the gastrointestinal tract and causes nausea and diarrhea. The incubation period is 8-10 days and symptoms persist between one and two weeks. Adenoviral infections may occur at any time of year. Astroviruses. Infect mostly infants and children less adults. The symptoms are watery diarrhea and vomiting, continuing for up to one week, and appears after an incubation period of 3-4 days. Symptoms were less severe than Norovirus or rotavirus infections. Astroviruses stomach flu are most common during the winter months.

Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.\nEvatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V.\nArch Neurol. 2008 Oct;65(10):1348-52.\nPMID: 18852350

With that innocent act, Viccars unleashed upon his community the most feared disease of the age. The package had come from London, where bubonic plague had been raging for months, and the cloth harbored fleas that carried the disease…By the end of September, five more people in the neighborhood had died, and in the first there days of October there were four more deaths. At the end of the month the toll had reached 23. The plague had come to the remote village of Eyam.

Mortality in a cohort with high fish consumption.\nTurunen AW, Verkasalo PK, Kiviranta H, Pukkala E, Jula A, Männistö S, Räsänen R, Marniemi J, Vartiainen T.\nInt J Epidemiol. 2008 Oct;37(5):1008-17. Epub 2008 Jun 25.\nPMID: 18579573

Fish intake, contaminants, and human health: evaluating the risks and the benefits. Mozaffarian D, Rimm EB. JAMA. 2006 Oct 18;296(15):1885-99. Review. Erratum in: JAMA. 2007 Feb 14;297(6):590. PMID: 17047219

Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.\nPilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H.\nJ Clin Endocrinol Metab. 2008 Oct;93(10):3927-35. Epub 2008 Aug 5.\nPMID: 18682515

Plasma 25-hydroxyvitamin D levels in young children undergoing placement of tympanostomy tubes.\nLinday LA, Shindledecker RD, Dolitsky JN, Chen TC, Holick MF.\nAnn Otol Rhinol Laryngol. 2008 Oct;117(10):740-4.\nPMID: 18998501

Conclusions/interpretation These results show that the previously demonstrated beneficial effects of these agents on complication-causing pathways in rodent models of diabetic complications also occur in humans with type 1 diabetes. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Du X, Edelstein D, Brownlee M. Diabetologia. 2008 Oct;51(10):1930-2. Epub 2008 Jul 29. PMID: 18663426 DOI: 10.1007/s00125-008-1100-2

"SCIENTISTS have shown that a new class of cancer drugs called PARP inhibitors, currently being tested in clinical trials to treat breast and ovarian cancer could have dramatic results when used to treat other solid tumours, according to work presented at the NCRI Cancer Conference today. "